Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

780
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
780
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

208
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
208
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

485
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
485
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

315
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
315
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

578
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
578
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

531
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
531

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATR-FTIR Assessment of the Antioxidant and Anti-Inflammatory Effects of (-)-Epicatechin in MASLD.

ACS omega·2026
Same author

Acute vascular redox modulation by SGLT2 inhibition in non-diabetic patients.

Cardiovascular diabetology. Endocrinology reports·2026
Same authorSame journal

The Association of Alpha-1 Antitrypsin Deficiency and Arterial Aneurysms: An Update and Review.

Journal of clinical and translational hepatology·2026
Same authorSame journal

Dubin-Johnson and Rotor Syndromes: A Review and Update of Pathophysiological Mechanisms.

Journal of clinical and translational hepatology·2026
Same author

Congenital Portosystemic Shunts: A Review.

Journal of clinical and translational hepatology·2026
Same author

Analysis of Protein Binding to Liver Mitochondria by Horizontal Polyacrylamide Gel Electrophoresis Using a Converted Agarose Electrophoresis Unit.

Journal of clinical and translational hepatology·2026

Related Experiment Video

Updated: Jan 22, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

10.8K

HCV Extrahepatic Manifestations.

Lucija Kuna1, Jelena Jakab2,3, Robert Smolic2,4

  • 1Department of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health, J. J. Strossmayer University of Osijek, Osijek, Croatia.

Journal of Clinical and Translational Hepatology
|July 12, 2019
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) can cause serious health issues beyond the liver, known as extrahepatic manifestations (EMs). Antiviral therapy is recommended for HCV patients with EMs, though not all symptoms may fully resolve.

Keywords:
B cell lymphomasDirect-acting antiviralsExtrahepatic manifestationsHepatic stellate cellsHepatitis C virusTGF-β-dependent signaling pathwaypancreatic B cell

More Related Videos

Generation of Organoids from Mouse Extrahepatic Bile Ducts
09:13

Generation of Organoids from Mouse Extrahepatic Bile Ducts

Published on: April 23, 2019

10.6K
Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
06:10

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

2.5K

Related Experiment Videos

Last Updated: Jan 22, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

10.8K
Generation of Organoids from Mouse Extrahepatic Bile Ducts
09:13

Generation of Organoids from Mouse Extrahepatic Bile Ducts

Published on: April 23, 2019

10.6K
Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates
06:10

Extrahepatic Bile Duct and Gall Bladder Dissection in Nine-Day-Old Mouse Neonates

Published on: August 23, 2022

2.5K

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infection extends beyond the liver, impacting multiple organs.
  • Extrahepatic manifestations (EMs) are common in HCV patients, affecting up to 74% of those with chronic infection.
  • While direct viral infection of extrahepatic tissues is rare, HCV-triggered immune responses are the primary cause of EMs.

Purpose of the Study:

  • To review the association between Hepatitis C virus and its extrahepatic manifestations.
  • To highlight the immune-mediated mechanisms underlying HCV-related EMs.
  • To discuss the implications of EMs for patient management and treatment.

Main Methods:

  • Literature review of studies on Hepatitis C virus and extrahepatic manifestations.
  • Analysis of immune-mediated pathways contributing to EMs.
  • Evaluation of treatment outcomes for HCV patients with EMs.

Main Results:

  • HCV is linked to various EMs, including cryoglobulinemia, lymphoma, insulin resistance, type 2 diabetes, and neurological disorders.
  • Immune-mediated mechanisms are responsible for the majority of HCV-associated EMs.
  • Sustained virological response to antiviral therapy does not guarantee complete resolution of all EMs.

Conclusions:

  • Extrahepatic manifestations are a significant complication of chronic Hepatitis C virus infection.
  • Understanding the immune basis of EMs is crucial for effective management.
  • Antiviral therapy should be considered for all HCV patients with EMs, with careful monitoring of treatment response.